Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization
By
Feliciano Yu
Joe Tafur
Francisco Moreno
Stephen Dahmer
May 13, 2026
Clinical Scorecard: First Year of Regulated Psilocybin Services in Oregon: An Analysis of Safety, User Motivations, and Service Utilization
At a Glance
Category Detail
Condition Key Mechanisms Target Population Care Setting
Key Highlights
5,935 clients participated in 5,375 sessions in 2025 32.6% of participants were from outside Oregon Majority of clients aged 35-49, with significant representation of women and LGBQ+ individuals Adverse events were rare, with rates of 2.42 behavioral and 2.79 medical per 1,000 sessions Racial diversity among participants was limited, with 84.1%-91.5% being White Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Monitor for adverse behavioral and medical reactions during sessions Implement strategies to improve racial diversity among participants Patient & Prescribing Data
Adults seeking psilocybin services for wellness and mental health
Participants reported motivations including wellness, mental health, trauma, and spiritual growth
Clinical Best Practices
Ensure administration in controlled settings to maximize safety Implement thorough screening and intention setting prior to sessions Facilitate integration sessions to discuss experiences post-administration Related Resources & Content
